Emergent BioSolutions Inc. (EBS) › Cash & EquivalentsEmergent BioSolutions Inc. (EBS) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-31: $91.47M2009-12-31: $102.92M2010-12-31: $169.02M2011-12-31: $143.90M2012-12-31: $141.67M2013-12-31: $179.34M2014-12-31: $280.50M2015-12-31: $312.80M2016-12-31: $271.50M2017-12-31: $178.30M2018-12-31: $112.20M2019-12-31: $167.80M2020-12-31: $621.30M2021-12-31: $576.10M2022-12-31: $642.60M2023-12-31: $111.70M2024-12-31: $99.50M2025-12-31: $205.40M$205.40M2008-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$205.40M+106.4%2026-02-27Balance as of period end2024-12-31$99.50M-10.9%2026-02-27Balance as of period end2023-12-31$111.70M-82.6%2026-02-27Balance as of period end2022-12-31$642.60M+11.5%2025-03-04Balance as of period end2021-12-31$576.10M-7.3%2023-12-11Balance as of period end2020-12-31$621.30M+270.3%2023-12-11Balance as of period end2019-12-31$167.80M+49.6%2022-02-25Balance as of period end2018-12-31$112.20M-37.1%2021-02-19Balance as of period end2017-12-31$178.30M-34.3%2020-02-25Balance as of period end2016-12-31$271.50M-13.2%2019-02-22Balance as of period end2015-12-31$312.80M+11.5%2019-02-22Balance as of period end2014-12-31$280.50M+56.4%2018-02-23Balance as of period end2013-12-31$179.34M+26.6%2017-02-28Balance as of period end2012-12-31$141.67M-1.6%2016-02-29Balance as of period end2011-12-31$143.90M-14.9%2015-03-09Balance as of period end2010-12-31$169.02M+64.2%2014-03-10Balance as of period end2009-12-31$102.92M+12.5%2013-03-08Balance as of period end2008-12-31$91.47M—2012-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)